Pharma Mirror
MARCH 31, 2022
The leading European pharmaceutical marketplace now hosts more than 85 000 CTD dossiers for finished dosage formulation products. New finished dosage form categories for medical devices and nutraceuticals will also be launched in the coming months. While quantity is sometimes a quality in itself, our product listings are curated by.
Pharma Mirror
APRIL 13, 2021
To ensure accurate dosage and administration, the powders used in these delivery systems require excellent flowability. BENEO’s filler-binder galenIQ™ 721 meets this demand and helps formulators to develop more convenient dosage forms. Consumers appreciate their ease of use and the ability to take them without water.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Mirror
OCTOBER 15, 2021
Effervescent dosage forms offer distinct advantages compared with traditional tablets. The post BENEO’s galenIQ™ 721 filler-binder optimizes the production of fizzy tablets and powders appeared first on Pharma Mirror Magazine. Forinstance, many patients have problems swallowing tablets. In addition, they can be usedto formulate.
Pharma Marketing Network
DECEMBER 13, 2024
Television and Print: While digital is dominant, TV and magazines still play a role, especially for older audiences. Instagram for Patients: Use visuals to simplify complex topics, like dosage instructions or potential side effects. AI-Powered Insights Artificial Intelligence can refine advertising strategies.
ISPE
OCTOBER 27, 2022
Oligos generally have excellent stability in aqueous solutions, and lyophilized oligos are dissolved in aqueous formulation buffers for preparation of the final dosage form anyway. Unfortunately, lyophilization is energy intensive and time consuming, often requiring 3 to 5 days to complete a batch. Cell & Gene Therapy. Company Name.
ISPE
MARCH 29, 2023
The TPP defines the indication and patient population, describes usage of the product, provides dosage and administration details, explains dosage form and strengths, and lists packaging and storage requirements. Table 3: Tabulated critical elements of the comprehensive control strategy summarized in the comprehensive QOS.
ISPE
MARCH 29, 2023
The TPP defines the indication and patient population, describes usage of the product, provides dosage and administration details, explains dosage form and strengths, and lists packaging and storage requirements. Table 3: Tabulated critical elements of the comprehensive control strategy summarized in the comprehensive QOS.
Expert insights. Personalized for you.
52 
Let's personalize your content